West Pharmaceutical Services Inc (WST) Growth Rates Comparisons to Medical Equipment & Supplies Industry, Sector, Market. Sales, Income, EPS
CSIMarket Company Name, Ticker, Suppliers, else..
 
West Pharmaceutical Services Inc   (NYSE: WST)
 

West Pharmaceutical Services Inc Growth Comparisons

Select each growth Category to receive further Information




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

WST Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q2 MRQ) 13.89 % 6.57 % 8.96 % 10.9 %
Q / Q Revenue Growth (Q2 MRQ) 3.3 % -1.87 % -3.29 % 8.32 %
Y / Y Revenue Growth (for 12 months ending Q2 TTM) 12.43 % 7.21 % 8.62 % %
Sequential Revenue Growth (for 12 months ending Q2 TTM) 3.3 % 1.5 % 2.01 % 2.61 %
Revenue 5 Year Average Growth 7.44 % 10.68 % 9.34 % 13.48 %


WST's Growth Comparisons in II. Quarter 2026




West Pharmaceutical Services Inc improved it's Revenue by 13.89% year on year in the second quarter 2026, and outpaced the 6.57% growth in the Medical Equipment & Supplies industry, and 8.96% growth in the Healthcare sector. Despite modest Sales rises in the Healthcare sector and in the Medical Equipment & Supplies industry, West Pharmaceutical Services Inc reported above average market Sales growth.

Comparing the company's Revenue to the first quarter results, sales were higher by 3.3% . On the yearly basis, average annual sales growth for West Pharmaceutical Services Inc is 7.44%, while S & P 500's including only Businesses with the second quarter 2026 earnings, average annual sales growth is 13.48% over the past five years.

WST Growth Rates by Company's Segments

Segment Name
Y / Y
Sequential
Proprietary Products
128.61 %
104.08 %
West Vantage
-
99.4 %
Total
13.89 %
3.3 %


Growth Rates of WST's Income in the second quarter 2026


WST Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q2 MRQ) 16.53 % 11.6 % 4.74 % 97.6 %
Sequential Operating Income Change (Q2 MRQ) 1.13 % 96.14 % 1.4 % 48.13 %
Y / Y Operating Income Growth (Q2 TTM) 16.99 % 13.68 % 30.73 % 40.67 %
Sequential Operating Income Growth (Q2 TTM) 3.88 % 2.92 % 4.82 % 20.86 %
Operating Income 5 Year Avg. Change 7.53 % 11.5 % 10.62 % 28.66 %


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q2 MRQ) 16.84 % -10.42 % -26.27 % 90.69 %
Sequential Income from Cont. Ops. Change (Q2 MRQ) 10.95 % 19.69 % -66.19 % 27.07 %
Y / Y Income from Cont. Ops. Change (Q2 TTM) 15.83 % 16.79 % 2.68 % 57.33 %
Sequential Income from Cont. Ops. Change (Q2 TTM) 4.09 % -2.7 % -5.02 % 18.65 %
Income from Cont. Ops. 5 Year Avg. Change 7.36 % 5.35 % 8.95 % -24.17 %

WST Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q2 MRQ) 16.84 % -12.37 % -26.24 % 90.69 %
Q / Q Net Income Growth (Q2 MRQ) 10.95 % 44.98 % -1.54 % 27.07 %
Y / Y Net Income Change (Q2 TTM) 15.83 % -0.27 % 15.47 % 57.33 %
Sequential Net Income Change (Q2 TTM) 4.09 % -3.32 % -6.72 % 18.65 %
Net Income 5 Year Avg. Growth 7.36 % 4.12 % 9.41 % 30.75 %

WST's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q2 MRQ) 19.23 % -16.22 % -26.27 % 90.69 %
Sequential EPS from Cont. Ops. Change (Q2 MRQ) 12.44 % 15.73 % -66.19 % 27.07 %
Y / Y EPS from Cont. Ops. Change (Q2 TTM) 17.24 % - - -
Sequential EPS from Cont. Ops. Change (Q2 TTM) 4.66 % - - 4.88 %
EPS from Cont. Ops. 5 Year Avg. Growth 7.85 % -1.8 % 8.95 % -24.17 %



WST EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q2 MRQ) 18.13 % -18.04 % -26.24 % -24.17 %
Q / Q EPS Net Growth (Q2 MRQ) 11.98 % 40.18 % -1.54 % 27.07 %
Y / Y EPS Net Change (for 12 months ending Q2 TTM) - - - 7.62 %
Sequential EPS Net Change (for 12 months ending Q2 TTM) 4.41 % - - 4.93 %
EPS Net 5 Year Avg. Change 8.24 % 4.12 % 9.41 % 30.75 %



West Pharmaceutical Services Inc reported 18.13% year on year EPS improvement in the second quarter to $2.15, although Medical Equipment & Supplies industry declined by -18.04%, Healthcare sector dropped -26.24%. Slow second quarter 2026 income per share, in Medical Equipment & Supplies industry and Healthcare sector, were portrayed in the West Pharmaceutical Services Inc results which underperformed overall market.

The bottom-line improved by 11.98% from the first quarter. Looking into annual income per share rise of 8.24%, and S & P 500's average yearly income per share growth is 30.75% over the five years, including only Businesses with the second quarter 2026 earnings reports. West Pharmaceutical Services Inc grew less than the market.

WST Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q2 MRQ) -20.71 % 63.84 % 49.73 % 48.62 %
Sequential Free Cash Flow Change (Q2 MRQ) 71.19 % -54.08 % -47.17 % 34.18 %
Y / Y Free Cash Flow Change (Q2 TTM) 27.01 % 41.37 % 18.93 % 60.27 %
Sequential Free Cash Flow Change (Q2 TTM) -4.61 % 7.23 % 5.38 % 15.75 %
Free Cash Flow 5 Year Avg. Change 9.48 % 3.81 % 1.82 % 18.38 %

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q2 MRQ) - - - 339.02 %
Sequential Net Cash Flow Change (Q2 MRQ) - - - 216.68 %
Y / Y Net Cash Flow Change (Q2 TTM) -81.57 % - - 209.43 %
Sequential Net Cash Flow Change (Q2 TTM) - - -12.2 % 152.64 %
Net Cash Flow 5 Year Avg. Change 11.7 % -9.69 % 6.07 % 4.29 %

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q2 MRQ) -42.55 % 4.81 % 8.24 % 120.03 %
Sequential Capital Expenditures Change (Q2 MRQ) 1.17 % -21.5 % -21.55 % 36.87 %
Y / Y Capital Expenditures Change (Q2 TTM) -32.28 % -1.63 % 8.45 % 109.38 %
Sequential Capital Expenditures Change (Q2 TTM) -12.44 % -1.55 % 2.14 % 23.05 %
Capital Expenditures 5 Year Avg. Change 10.39 % 8.35 % 7.99 % 12.12 %

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Y/Y Annual




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.